10x Genomics Inc (Class A) Live Stock Price Today, Share Analysis and Chart

Name: 10x Genomics Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: 10x Genomics Inc - Ordinary Shares - Class A
Rating: 1.55691675
Author: Trendlyne DVM scores

Momentum Trap

about

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and ...

21.58 -0.85 (-3.79%)

179.53% Gain from 52W Low

936.0K

XNAS Volume

XNAS 04 May, 2026 12:24 PM (EDT)

Board Meeting

The next board meeting for 10x Genomics Inc (Class A) is on 13 May 2026 for the purpose of BofA Securities 2026 Healthcare Conference See details

Low Financial Strength

16.7 / 100

Expensive Valuation

24.5 / 100

Technically Moderately Bullish

66.7 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 11%

13 analysts

10x Genomics Inc (Class A) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

10x Genomics Inc (Class A) Live Stock Price Today, Share Analysis and Chart

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and ...

179.53% Gain from 52W Low

SWOT Analysis

10x Genomics Inc (Class A) Live Price Chart